Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Philips | Amsterdam | Healthcare | Healthcare Equipment & Supplies | €18.88B | -26.9x | 0.42 | €20.41 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 32.3% Upside | Upgrade to Pro+ | |
Galapagos | Amsterdam | Healthcare | Biotechnology & Medical Research | €1.39B | -1,163x | 16.72 | €21.16 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 41.8% Upside | Upgrade to Pro+ | |
Pharming Group | Amsterdam | Healthcare | Pharmaceuticals | €470.54M | -45.4x | 3.72 | €0.69 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vivoryon Therapeutics | Amsterdam | Healthcare | Biotechnology & Medical Research | €46.09M | -1.9x | 0.1 | €1.77 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |